1. Home
  2. Analysis
  3. Benzonatate
  4. Pulmonary-function-test-decreased

Benzonatate and Pulmonary function test decreased - a phase IV clinical study of FDA data

Summary:

Pulmonary function test decreased is reported as a side effect among people who take Benzonatate (benzonatate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ultracet, and have Idiopathic pulmonary fibrosis.

The phase IV clinical study analyzes which people have Pulmonary function test decreased when taking Benzonatate. It is created by eHealthMe based on reports of 16,665 people who have side effects when taking Benzonatate from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Pulmonary function test decreased?

Pulmonary function test decreased is found to be associated with 460 drugs and 501 conditions by eHealthMe. Check the latest studies of Pulmonary function test decreased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

16,665 people reported to have side effects when taking Benzonatate.
Among them, 13 people (0.08%) have Pulmonary function test decreased.

Could Benzonatate cause Pulmonary function test decreased?

Among these 13 people:

How long have people been on Benzonatate when they have Pulmonary function test decreased? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Pulmonary function test decreased when taking Benzonatate? *

  • female: 53.85 %
  • male: 46.15 %

What is the age of people who have Pulmonary function test decreased when taking Benzonatate? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 20 %
  • 40-49: 0.0 %
  • 50-59: 10 %
  • 60+: 70 %

What are other drugs people take besides Benzonatate? *

  1. Simvastatin: 3 people, 23.08%
  2. Augmentin: 3 people, 23.08%
  3. Esbriet: 3 people, 23.08%
  4. Ultracet: 3 people, 23.08%
  5. Metformin: 2 people, 15.38%
  6. Flonase Allergy Relief: 2 people, 15.38%
  7. Meclizine: 2 people, 15.38%
  8. Promethazine: 2 people, 15.38%
  9. Combivent: 2 people, 15.38%
  10. Acetaminophen: 2 people, 15.38%

What are other side effects people have besides Pulmonary function test decreased? *

  1. Joint Pain: 4 people, 30.77%
  2. Head Injury: 4 people, 30.77%
  3. Pneumonia: 4 people, 30.77%
  4. Rashes (redness): 3 people, 23.08%
  5. Pleurisy (inflammation of the pleurae, which causes pain when breathing): 3 people, 23.08%
  6. Fatigue (feeling of tiredness): 3 people, 23.08%
  7. White Blood Cell Count Increased: 2 people, 15.38%
  8. Headache (pain in head): 2 people, 15.38%
  9. Flatulence (flatus expelled through the anus): 2 people, 15.38%
  10. Haemoglobin Decreased: 2 people, 15.38%

What are the existing conditions these people have? *

  1. Idiopathic Pulmonary Fibrosis (chronic lung disease): 5 people, 38.46%
  2. Insomnia (sleeplessness): 3 people, 23.08%
  3. Arrhythmias (irregular heartbeat): 2 people, 15.38%
  4. High Blood Pressure: 2 people, 15.38%
  5. Type 2 Diabetes: 2 people, 15.38%
  6. Back Pain: 2 people, 15.38%
  7. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 15.38%
  8. Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 2 people, 15.38%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 7.69%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and have Pulmonary function test decreased?

- Check whether Pulmonary function test decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Benzonatate:

Pulmonary function test decreased treatments and more:

How severe was Pulmonary function test decreased and when was it recovered:

Expand to all the drugs that have ingredients of benzonatate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Benzonatate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary function test decreased:

Browse all the conditions that are associated with Pulmonary function test decreased:

How the study uses the data?

The study uses data from the FDA. It is based on benzonatate (the active ingredients of Benzonatate) and Benzonatate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.